Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating a monoclonal antibody therapy for advanced kidney cancer has completed, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Kidney Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-01-05